IPSEN SA SPONS ADR EA REPR 0.25 ORDのニュース一覧

Eton Pharmaceuticals Enters Asset Purchase Agreement To Acquire Increlex (Mecasermin Injection) From Ipsen; No Terms Disclosed

Benzinga10/03 18:34

Gilead Wins FDA Nod for Liver Disease Drug

Seeking Alpha08/15 02:25

Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod

Seeking Alpha08/10 20:13

IPSEN - Buy-back Programme - Art 5 of MAR - Week 30 - 2024

Yahoo Finance07/31 00:00

Ipsen Liver Disease Drugs Endorsed in EU

Seeking Alpha07/26 22:31

Ipsen And Day One Earlier Announced Exclusive Ex U.S. Licensing Agreement To Commercialize Tovorafenib For The Most Common Childhood Brain Tumor

Benzinga07/25 18:10

Ipsen S.A. Non-GAAP EPS of €4.78, Revenue of €1.66B; Raises FY24 Outlook

Seeking Alpha07/25 15:47

Ipsen And Day One Enter Ex-U.S. Licensing Deal For Pediatric Brain Cancer Drug Tovorafenib

Benzinga07/25 13:54

IPSEN - Buy-back Programme - Art 5 of MAR - Week 28 - 2024

Yahoo Finance07/17 00:00

Ipsen, Foreseen Enter Exclusive Global Licensing Agreement for Antibody-drug Conjugate

Seeking Alpha07/11 16:14

Ipsen - June 2024 - Monthly Information Relative to the Total Number of Voting Rights and Shares Composing the Share Capital

Yahoo Finance07/10 00:00

IPSEN - Buy-back Programme - Art 5 of MAR - Week 27 - 2024

Yahoo Finance07/10 00:00

Hutchmed Gains as Ipsen-partnered Lymphoma Drug Undergoes Review in China

Seeking Alpha07/06 01:41

Ipsen Expands Collaboration Agreement With Exelixis

Seeking Alpha07/02 15:34

IPSEN - Buy-back Programme - Art 5 of MAR - Week 23 - 2024

Yahoo Finance06/12 00:00

FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo

Benzinga06/11 21:18

Ipsen Gains Accelerated Approval for Elafibranor for Rare Liver Disease

Seeking Alpha06/11 05:33

GENFIT Says Iqirvo Is First-ever Drug Developed In-house By Company To Achieve FDA Approval; Expects To Receive Milestone Payments From Ipsen

Benzinga06/11 05:26

Ipsen and Marengo Therapeutics Announce Second Strategic Partnership

Seeking Alpha06/07 20:53

Ipsen Presents Long-term Elafibranor Efficacy and Itch-related Quality of Life Data in Patients With Primary Biliary Cholangitis

GlobeNewswire06/05 14:00